Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 33 (3), 458-463
- https://doi.org/10.1016/s0272-6386(99)70182-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Pentoxifylline Maintains Hepatocellular Function and Improves Cardiac Performance during Early SepsisJournal Of Trauma-Injury Infection and Critical Care, 1997
- Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shockIntensive Care Medicine, 1996
- Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shockCritical Care Medicine, 1996
- Pentoxifylline in Management of Proteinuria in Diabetic NephropathyNephron, 1993
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Physiopathology and Clinical Aspects of Diabetic NephropathyNephron, 1988
- PentoxifyllineDrugs, 1987
- Effects of recombinant human tumor necrosis factor (rhtnf) on normal human and mouse hemopoietic progenitor cellsThe International Journal of Cell Cloning, 1987
- RANDOMISED TRIAL OF PENTOXIFYLLINE VERSUS ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE IN PREVENTING TRANSIENT ISCHAEMIC ATTACKSThe Lancet, 1981